Department of Ophthalmology, Stavanger University Hospital, Stavanger, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Department of Ophthalmology, Stavanger University Hospital, Stavanger, Norway; Department of Quality and Health Technology, University of Stavanger, Stavanger, Norway.
Ocul Surf. 2024 Apr;32:222-226. doi: 10.1016/j.jtos.2024.03.004. Epub 2024 Mar 13.
To investigate cytokine levels in the tear fluid of patients receiving serial intravitreal injections (IVI) with anti-vascular endothelial growth factor (anti-VEGF) for neovascular age-related macular degeneration (nAMD).
Concentrations of six cytokines (IFN-γ, IL-1β, IL-6, IL-8, TNF and VEGF) in tears of patients receiving anti-VEGF in one eye were assayed using multiplex cytometric bead array. The fellow untreated eye served as control. Tear sampling was performed on a single occasion at a minimum of four weeks after IVI. Patients underwent a pre-IVI antisepsis protocol with povidone-iodine.
Tear fluid from thirty patients with a mean age of 78.8 years (range 58-90) was assayed. Subjects received a median of 43.5 (range 22-106) IVI in one eye. The median level of IFN-γ was 0.33 (interquartile range (IQR) 0.22-0.52) pg/mg of total protein in injected eyes versus 0.41 (IQR 0.21-1.05) pg/mg in fellow eyes (p = 0.017). For TNF, a median level of 0.12 (IQR 0.08-0.18) pg/mg of total protein was found in injected eyes versus 0.14 (IQR 0.07-0.33) pg/mg of total protein in fellow eyes (p = 0.019). There were no differences between injected and fellow eyes regarding the levels of IL-1β, IL-6, IL-8 and VEGF.
Tear fluid in eyes receiving serial IVI with anti-VEGF and preoperative povidone-iodine antisepsis constitutes lower levels of the pro-inflammatory cytokines IFN-γ and TNF compared to fellow eyes. This provides biochemical support of previous findings of reduced signs of inflammation and healthier tear film parameters in patients treated with serial IVI.
研究接受抗血管内皮生长因子(anti-VEGF)连续玻璃体内注射(IVI)治疗新生血管性年龄相关性黄斑变性(nAMD)的患者的泪液细胞因子水平。
使用多重细胞因子微珠阵列分析接受抗 VEGF 治疗的一只眼中的 6 种细胞因子(IFN-γ、IL-1β、IL-6、IL-8、TNF 和 VEGF)在泪液中的浓度。未治疗的对侧眼作为对照。在 IVI 后至少 4 周的单个时间点进行泪液取样。患者在接受 IVI 前接受聚维酮碘的消毒方案。
对 30 名平均年龄为 78.8 岁(58-90 岁)的患者的泪液进行了检测。每位患者接受了一只眼中位数为 43.5(22-106)次 IVI。注射眼中 IFN-γ 的中位数水平为 0.33(四分位距(IQR)0.22-0.52)pg/mg 总蛋白,对侧眼为 0.41(IQR 0.21-1.05)pg/mg(p=0.017)。对于 TNF,注射眼中总蛋白的中位数水平为 0.12(IQR 0.08-0.18)pg/mg,对侧眼为 0.14(IQR 0.07-0.33)pg/mg(p=0.019)。注射眼和对侧眼的 IL-1β、IL-6、IL-8 和 VEGF 水平没有差异。
接受抗 VEGF 连续 IVI 和术前聚维酮碘消毒的眼睛的泪液中,促炎细胞因子 IFN-γ 和 TNF 的水平低于对侧眼。这为先前发现的接受连续 IVI 治疗的患者炎症迹象减少和泪膜参数更健康提供了生化支持。